Patient Safety Organizations: Voluntary Relinquishment From PDR Secure, LLC, 65892-65893 [2012-26598]
Download as PDF
65892
Federal Register / Vol. 77, No. 211 / Wednesday, October 31, 2012 / Notices
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: October 12, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012–26596 Filed 10–30–12; 8:45 am]
BILLING CODE M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meeting
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
AGENCY:
In accordance with section 10
(a)(2) of the Federal Advisory
Committee Act (5 U.S.C. App. 2),
announcement is made of an Agency for
Healthcare Research and Quality
(AHRQ) Special Emphasis Panel (SEP)
meeting on ‘‘AHRQ NATIONAL
RESEARCH SERVICE AWARDS (NRSA)
INSTITUTIONAL RESEARCH
TRAINING GRANTS (T32)’’.
DATES: November 14–15, 2012 (Open on
November 14 from 8:00 a.m. to 8:30 a.m.
and closed for the remainder of the
meeting).
SUMMARY:
Gaithersburg Marriott, RIO,
9751 Washingtonian Boulevard,
Gaithersburg, MD 20878.
FOR FURTHER INFORMATION CONTACT:
Anyone wishing to obtain a roster of
members, agenda or minutes of the nonconfidential portions of this meeting
should contact: Mrs. Bonnie Campbell,
Committee Management Officer, Office
of Extramural Research, Education and
Priority Populations, AHRQ, 540
Gaither Road, Room 2038, Rockville,
Maryland 20850, Telephone: (301) 427–
1554.
Agenda items for this meeting are
subject to change as priorities dictate.
SUPPLEMENTARY INFORMATION: A Special
Emphasis Panel is a group of experts in
fields related to health care research
who are invited by the Agency for
Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support.
Individual members of the Panel do
not attend regularly-scheduled meetings
and do not serve for fixed terms or a
tkelley on DSK3SPTVN1PROD with NOTICES
ADDRESSES:
VerDate Mar<15>2010
17:08 Oct 30, 2012
Jkt 229001
long period of time. Rather, they are
asked to participate in particular review
meetings which require their type of
expertise.
Substantial segments of the SEP
meeting referenced above will be closed
to the public in accordance with the
provisions set forth in 5 U.S.C. App. 2,
section 10(d), 5 U.S.C. 552b(c)(4), and 5
U.S.C. 552b(c)(6). Grant applications for
‘‘AHRQ NATIONAL RESEARCH
SERVICE AWARDS (NRSA)
INSTITUTIONAL RESEARCH
TRAINING GRANTS (T32)’’ are to be
reviewed and discussed at this meeting.
The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Dated: October 12, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012–26597 Filed 10–30–12; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Patient Safety Organizations:
Voluntary Relinquishment From PDR
Secure, LLC
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of Delisting.
AGENCY:
The Patient Safety and
Quality Improvement Act of 2005
(Patient Safety Act), Public Law 109–41,
42 U.S.C. 299b–21–b–26, provides for
the formation of Patient Safety
Organizations (PSOs), which collect,
aggregate, and analyze confidential
information regarding the quality and
safety of health care delivery. The
Patient Safety and Quality Improvement
Final Rule (Patient Safety Rule), 42 CFR
Part 3, authorizes AHRQ, on behalf of
the Secretary of HHS, to list as a PSO
an entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ by
the Secretary if it is found no longer to
meet the requirements of the Patient
Safety Act and Patient Safety Rule, or
when a PSO chooses to voluntarily
relinquish its status as a PSO for any
reason. AHRQ has accepted a
notification of voluntary relinquishment
from PDR Secure, LLC of its status as a
SUMMARY:
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
PSO, and has delisted the PSO
accordingly.
DATES: The directories for both listed
and delisted PSOs are ongoing and
reviewed weekly by AHRQ. The
delisting was effective at 12:00 Midnight
ET (2400) on August 31, 2012.
ADDRESSES: Both directories can be
accessed electronically at the following
HHS Web site: https://
www.pso.AHRQ.gov/.
FOR FURTHER INFORMATION CONTACT:
Eileen Hogan, Center for Quality
Improvement and Patient Safety, AHRQ,
540 Gaither Road, Rockville, MD 20850;
Telephone (toll free): (866) 403–3697;
Telephone (local): (301) 427–1111; TTY
(toll free): (866) 438–7231; TTY (local):
(301) 427–1130; Email:
pso@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity is to
conduct activities to improve patient
safety and the quality of health care
delivery.
HHS issued the Patient Safety Rule to
implement the Patient Safety Act.
AHRQ administers the provisions of the
Patient Safety Act and Patient Safety
Rule (PDF file, 450 KB. PDF Help)
relating to the listing and operation of
PSOs. The Patient Safety Rule
authorizes AHRQ to list as a PSO an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ if
it is found no longer to meet the
requirements of the Patient Safety Act
and Patient Safety Rule, or when a PSO
chooses to voluntarily relinquish its
status as a PSO for any reason. Section
3.108(d) of the Patient Safety Rule
requires AHRQ to provide public notice
when it removes an organization from
the list of federally approved PSOs.
AHRQ has accepted a notification
from PDR Secure, LLC, PSO number
P0098, which is a component entity of
PDR Network, LLC, to voluntarily
relinquish its status as a PSO.
Accordingly, PDR Secure, LLC was
delisted effective at 12:00 Midnight ET
(2400) on August 31, 2012. PDR
Network, LLC represents that it has
patient safety work product (PSWP) in
its possession. The PSO is obligated to
meet the requirements of section
3.108(c)(2)(i) of the Patient Safety Rule
to notify the sources from which it
received PSWP of the PSO’s intention to
cease PSO operations and activities, to
relinquish voluntarily its status as a
PSO, to request that these other entities
E:\FR\FM\31OCN1.SGM
31OCN1
65893
Federal Register / Vol. 77, No. 211 / Wednesday, October 31, 2012 / Notices
cease reporting or submitting any
further information to the PSO as soon
as possible, and to inform them that any
information reported after the effective
date and time of delisting will not be
protected as PSWP under the Patient
Safety Act. In addition, according to
section 3.108(c)(2)(ii) of the Patient
Safety Rule regarding disposition of
PSWP, the PSO has 90 days from the
effective date of delisting and revocation
to complete the disposition of PSWP
that is currently in the PSO’s
possession.
More information on PSOs can be
obtained through AHRQ’s PSO Web site
at https://www.pso.AHRQ.gov/
index.html.
Dated: October 12, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012–26598 Filed 10–30–12; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60-Day–13–0488]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 and
send comments to Ron Otten, CDC
Reports Clearance Officer, 1600 Clifton
Road, MS–D74, Atlanta, GA 30333 or
send an email to omb@cdc.gov.
Comments are invited on (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have a
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of information technology. Written
comments should be received within 60
days of this notice.
Proposed Project
Restriction on Interstate Travel of
Persons (OMB Control No. 0920–0488
Exp. 3/31/2013)—Revision—National
Center Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention is requesting OMB approval
to extend the information collection
request, ‘‘Restriction on Interstate Travel
of Persons’’ (OMB Control No. 0920–
0488).
Form name
Traveler .............................................
42 CFR 70.3 Application to the
State of destination for a permit.
42 CFR 70.3 Copy of material submitted by applicant and permit
issued by State health authority.
42 CFR 70.3 Copy of material submitted by applicant and permit
issued by State health authority.
42 CFR 70.4 Report by specified
respondent of a communicable
disease during interstate travel
(Paper Form if requested by CDC
during public health emergency).
42 CFR 70.4 Copy of material submitted to state/local authority
(Paper Form if requested by CDC,
public health emergency).
42 CFR 70.4 Report by specified
respondent of a communicable
disease during interstate travel
(Radio or other telecommunication for routine reporting).
Attending physician ...........................
State health authority ........................
Master of a vessel or person in
charge of a conveyance.
tkelley on DSK3SPTVN1PROD with NOTICES
State health authority ........................
Master of a vessel or person in
charge of a conveyance.
VerDate Mar<15>2010
17:08 Oct 30, 2012
Jkt 229001
PO 00000
Frm 00042
Number of
responses per
respondent
Number of
respondents
Type of respondent
Fmt 4703
Sfmt 4703
This information collection request is
scheduled to expire on March 31, 2013.
CDC is authorized to collect this
information under 42 CFR 70.5 (Certain
communicable diseases; special
requirements). This regulation requires
that any person who is in the
communicable period for cholera,
plague, smallpox, typhus, or yellow
fever or having been exposed to any
such disease is in the incubation period
thereof, to apply for and receive a
permit from the Surgeon General or his
authorized representative in order to
travel from one State or possession to
another.
Control of disease transmission
within the States is considered to be the
province of state and local health
authorities, with Federal assistance
being sought by those authorities on a
cooperative basis without application of
Federal regulations. The regulations in
42 Part 70 were developed to facilitate
Federal action in the event of large
outbreaks requiring a coordinated effort
involving several states, or in the event
of inadequate local control. While it is
not known whether, or to what extent
situations may arise in which these
regulations would be invoked,
contingency planning for domestic
emergency preparedness is now
commonplace. Should these situations
arise, CDC will use the reporting and
recordkeeping requirements contained
in the regulations to carry out
quarantine responsibilities as required
by law.
There is no cost to respondents other
than their time.
Average
burden per
response
(in hours)
Total burden
(in hours)
2,000
1
15/60
500
2,000
1
15/60
500
8
250
6/60
200
1,500
1
15/60
375
20
75
6/60
150
200
1
15/60
50
E:\FR\FM\31OCN1.SGM
31OCN1
Agencies
[Federal Register Volume 77, Number 211 (Wednesday, October 31, 2012)]
[Notices]
[Pages 65892-65893]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-26598]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Patient Safety Organizations: Voluntary Relinquishment From PDR
Secure, LLC
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice of Delisting.
-----------------------------------------------------------------------
SUMMARY: The Patient Safety and Quality Improvement Act of 2005
(Patient Safety Act), Public Law 109-41, 42 U.S.C. 299b-21-b-26,
provides for the formation of Patient Safety Organizations (PSOs),
which collect, aggregate, and analyze confidential information
regarding the quality and safety of health care delivery. The Patient
Safety and Quality Improvement Final Rule (Patient Safety Rule), 42 CFR
Part 3, authorizes AHRQ, on behalf of the Secretary of HHS, to list as
a PSO an entity that attests that it meets the statutory and regulatory
requirements for listing. A PSO can be ``delisted'' by the Secretary if
it is found no longer to meet the requirements of the Patient Safety
Act and Patient Safety Rule, or when a PSO chooses to voluntarily
relinquish its status as a PSO for any reason. AHRQ has accepted a
notification of voluntary relinquishment from PDR Secure, LLC of its
status as a PSO, and has delisted the PSO accordingly.
DATES: The directories for both listed and delisted PSOs are ongoing
and reviewed weekly by AHRQ. The delisting was effective at 12:00
Midnight ET (2400) on August 31, 2012.
ADDRESSES: Both directories can be accessed electronically at the
following HHS Web site: https://www.pso.AHRQ.gov/.
FOR FURTHER INFORMATION CONTACT: Eileen Hogan, Center for Quality
Improvement and Patient Safety, AHRQ, 540 Gaither Road, Rockville, MD
20850; Telephone (toll free): (866) 403-3697; Telephone (local): (301)
427-1111; TTY (toll free): (866) 438-7231; TTY (local): (301) 427-1130;
Email: pso@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety Act authorizes the listing of PSOs, which are
entities or component organizations whose mission and primary activity
is to conduct activities to improve patient safety and the quality of
health care delivery.
HHS issued the Patient Safety Rule to implement the Patient Safety
Act. AHRQ administers the provisions of the Patient Safety Act and
Patient Safety Rule (PDF file, 450 KB. PDF Help) relating to the
listing and operation of PSOs. The Patient Safety Rule authorizes AHRQ
to list as a PSO an entity that attests that it meets the statutory and
regulatory requirements for listing. A PSO can be ``delisted'' if it is
found no longer to meet the requirements of the Patient Safety Act and
Patient Safety Rule, or when a PSO chooses to voluntarily relinquish
its status as a PSO for any reason. Section 3.108(d) of the Patient
Safety Rule requires AHRQ to provide public notice when it removes an
organization from the list of federally approved PSOs.
AHRQ has accepted a notification from PDR Secure, LLC, PSO number
P0098, which is a component entity of PDR Network, LLC, to voluntarily
relinquish its status as a PSO. Accordingly, PDR Secure, LLC was
delisted effective at 12:00 Midnight ET (2400) on August 31, 2012. PDR
Network, LLC represents that it has patient safety work product (PSWP)
in its possession. The PSO is obligated to meet the requirements of
section 3.108(c)(2)(i) of the Patient Safety Rule to notify the sources
from which it received PSWP of the PSO's intention to cease PSO
operations and activities, to relinquish voluntarily its status as a
PSO, to request that these other entities
[[Page 65893]]
cease reporting or submitting any further information to the PSO as
soon as possible, and to inform them that any information reported
after the effective date and time of delisting will not be protected as
PSWP under the Patient Safety Act. In addition, according to section
3.108(c)(2)(ii) of the Patient Safety Rule regarding disposition of
PSWP, the PSO has 90 days from the effective date of delisting and
revocation to complete the disposition of PSWP that is currently in the
PSO's possession.
More information on PSOs can be obtained through AHRQ's PSO Web
site at https://www.pso.AHRQ.gov/.
Dated: October 12, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012-26598 Filed 10-30-12; 8:45 am]
BILLING CODE 4160-90-M